Design of Experiments Grants Mechanistic Insights into the Synthesis of Spermine-Containing PBAE Copolymers
Source abstract
Abstract
Successful therapeutic delivery of siRNA with polymeric nanoparticles seems to be a promising but not vastly understood and complicated goal to achieve. Despite years of research, no polymer-based delivery system has been approved for clinical use. Polymers, as a delivery system, exhibit considerable complexity and variability, making their consistent production a challenging endeavor. However, a better understanding of the polymerization process of polymer excipients may improve the reproducibility and material quality for more efficient use in drug products. Here, we present a combination of Design of Experiment and Python-scripted data science to establish a prediction model, from which important parameters can be extracted that influence the synthesis results of polybeta-amino esters (PBAEs), a common type of polymer used preclinically for nucleic acid delivery. We synthesized a library of 27 polymers, each one at different temperatures with different reaction times and educt ratios using an orthogonal central composite (CCO-) design. This design allowed a detailed characterization of factor importance and interactions using a very limited number of experiments. We characterized the polymers by analyzing the resulting composition by 1H-NMR and the size distribution by GPC measurements. To further understand the complex mechanism of block polymerization in a one-pot synthesis, we developed a Python script that helps us to understand possible step-growth steps. We successfully developed and validated a predictive response surface and gathered a deeper understanding of the synthesis of polyspermine-based amphiphilic PBAEs.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Nanopore and Nanochannel Transport Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Pharmaceutical Technology and Biopharmaceutics, Department of Pharmacy, Ludwig-Maximilians-University München, Munich 81377, Germany
Université Paris Cité, Paris 75015, France
Center for NanoScience Munich (CeNS), Munich 81377, Germany
Cluster for Nucleic Acid Therapeutics Munich (CNATM), Munich 81377, Germany
Funding
HORIZON EUROPE European Research Council · Bundesministerium f?r Bildung und Forschung
References (38)
Show source-provided references
1. 10.1002/adma.20230326110.1002/adma.202303261 ↗
2. 10.1016/j.copbio.2021.09.01610.1016/j.copbio.2021.09.016 ↗
3. 10.1080/17425247.2023.216287610.1080/17425247.2023.2162876 ↗
4. 10.1016/j.ijpharm.2021.12058610.1016/j.ijpharm.2021.120586 ↗
5. 10.1021/ja001538810.1021/ja0015388 ↗
6. 10.1002/adma.20180511610.1002/adma.201805116 ↗
7. 10.1126/sciadv.abk285510.1126/sciadv.abk2855 ↗
8. 10.1016/j.ymthe.2004.11.01510.1016/j.ymthe.2004.11.015 ↗
9. 10.1002/adhm.20180024910.1002/adhm.201800249 ↗
10. 10.1016/j.biomaterials.2019.04.02010.1016/j.biomaterials.2019.04.020 ↗
11. 10.1021/acsami.3c0380210.1021/acsami.3c03802 ↗
12. 10.1021/acsami.3c0501010.1021/acsami.3c05010 ↗
13. 10.1016/j.biomaterials.2012.01.04610.1016/j.biomaterials.2012.01.046 ↗
14. 10.1016/j.jconrel.2006.04.01410.1016/j.jconrel.2006.04.014 ↗
15. 10.1021/bc990025r10.1021/bc990025r ↗
16. 10.1002/9781119722717.ch1110.1002/9781119722717.ch11 ↗
17. 10.1021/acsabm.2c0034610.1021/acsabm.2c00346 ↗
18. 10.1021/acsabm.2c0096210.1021/acsabm.2c00962 ↗
19. 10.1038/s41563-024-01867-310.1038/s41563-024-01867-3 ↗
20. 10.1039/d3bm00741c10.1039/d3bm00741c ↗
21. 10.1021/acsnano.9b0177410.1021/acsnano.9b01774 ↗
22. 10.1021/acsami.6b0437010.1021/acsami.6b04370 ↗
23. 10.1016/j.jconrel.2024.02.00210.1016/j.jconrel.2024.02.002 ↗
24. 10.31276/VJSTE.61(1).09-1310.31276/VJSTE.61(1).09-13 ↗
25. 10.1007/s10118-014-1467-010.1007/s10118-014-1467-0 ↗
26. 10.1021/acs.biomac.4c0028310.1021/acs.biomac.4c00283 ↗
27. 10.1021/acs.molpharmaceut.3c0020610.1021/acs.molpharmaceut.3c00206 ↗
28. 10.1039/D3NA00272A10.1039/D3NA00272A ↗
29. 10.1016/j.jconrel.2023.05.00110.1016/j.jconrel.2023.05.001 ↗
30. 10.1038/s41598-019-47846-610.1038/s41598-019-47846-6 ↗
31. 10.3390/nano907098610.3390/nano9070986 ↗
32. 10.3390/pharmaceutics1202008910.3390/pharmaceutics12020089 ↗
33. 10.1016/j.omtn.2023.04.01910.1016/j.omtn.2023.04.019 ↗
34. 10.14419/ijbas.v3i2.241610.14419/ijbas.v3i2.2416 ↗
35. 10.1021/ed058p86210.1021/ed058p862 ↗
36. 10.1021/jf903378x10.1021/jf903378x ↗
37. 10.1039/tf936320003910.1039/tf9363200039 ↗
38. 10.1021/acs.macromol.3c0122310.1021/acs.macromol.3c01223 ↗